Last edition
News about "tumour necrosis factor-like cytokine 1A"
Merck Reports Positive Phase 2b Tulisokibart Results in Hidradenitis Suppurativa
Merck reported Phase 2b results for investigational tulisokibart in patients with moderate to severe hidradenitis suppurativa.
Tumour Necrosis Factor-like Cytokine 1A | 01/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members